24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

Aristotle University Of Thessaloniki

Status and phase: Completed; Phase 3

Conditions: Exfoliation Syndrome; Primary Open Angle Glaucoma

Treatments: Drug: travoprost/timolol fixed combination; Drug: placebo (artificial tears)

Study type: Interventional

Funder types: Other

Identifiers

NCT00331240

A1457

Details and patient eligibility

About

The purpose of this study is to compare the short-term (8 week) mean 24-hour intraocular pressure control and safety of TravTim fixed combination given once in the evening with placebo once in the morning versus TravTim given once in the morning with placebo once in the evening in patients with open-angle glaucoma.

Sex: All

Ages: 29 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• POAG
• Exfoliation syndrome

Exclusion criteria

• Advanced glaucoma

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: Double Blind